aminocaproic acid has been researched along with Amyoplasia Congenita in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weyand, AC | 1 |
| Lombel, RM | 1 |
| Pipe, SW | 1 |
| Shavit, JA | 1 |
1 other study available for aminocaproic acid and Amyoplasia Congenita
| Article | Year |
|---|---|
The Role of Platelets and ε-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated Hemorrhage.
Topics: Aminocaproic Acid; Arthrogryposis; Blood Platelets; Cholestasis; Female; Hemorrhage; Heterozygote; H | 2016 |